MATN1: A Protein Targeted for Therapeutic Applications (G4146)

Target Name: MATN1

NCBI ID: G4146

MATN1

MATN1: A Protein Targeted for Therapeutic Applications

MATN1 (MATN1_HUMAN), a protein that belongs to the family of homeodetic transcription factors, plays a crucial role in the development and maintenance of normal tissues, including brain and spinal cord. MATN1 is expressed in a wide range of tissues and cells in the body, and its function is highly conserved across species.

MATN1 is involved in the regulation of gene expression and cell differentiation, as well as in the development and maintenance of tissues and organs. It has been shown to play a role in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Due to its involvement in so many cellular processes, MATN1 has become a promising drug target for a variety of diseases. Researchers are currently working to develop small molecules and other compounds that can inhibit the activity of MATN1 and its downstream targets, in order to treat a range of diseases.

One approach to targeting MATN1 is to use small molecules that can modulate its activity. Many of these molecules have been shown to be effective in inhibiting the activity of MATN1, and are currently being tested in preclinical studies for their potential use in treating a variety of diseases.

Another approach to targeting MATN1 is to use antibodies that can specifically recognize and target the protein. These antibodies have been shown to be effective in inhibiting the activity of MATN1 in a variety of cell types and have the potential to be used in a variety of therapeutic applications.

In addition to its potential use as a drug target, MATN1 is also being studied as a potential biomarker for a variety of diseases. Its expression has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. By using MATN1 as a biomarker, researchers may be able to develop more targeted and effective therapies for these diseases.

Overall, MATN1 is a protein that has the potential to be a valuable drug target and biomarker for a variety of diseases. Further research is needed to fully understand its function and to develop effective therapies based on its activity.

Protein Name: Matrilin 1

Functions: Cartilage matrix protein is a major component of the extracellular matrix of non-articular cartilage. It binds to collagen

The "MATN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MATN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets